OR WAIT null SECS
© 2022 MJH Life Sciences and Optometry Times. All rights reserved.
© 2022 MJH Life Sciences™ and Optometry Times. All rights reserved.
August 26, 2022
Leo P. Semes, OD, FAAO, discusses his presentation on, "A new look at AMD," during the South Carolina Optometric Physicians Association's annual meeting.
August 24, 2022
Latest data from phase 3 studies finds increased effects over time with intravitreal pegcetacoplan for geographic atrophy secondary to age-related macular degeneration.
August 22, 2022
New DME treatments aim to extend time between intravitreal injections.
August 19, 2022
A recent clinical trial from the DRCR Retina Network examined a stepped regimen of anti-VEGF drugs bevacizumab and aflibercept.
August 11, 2022
IBI324 is a potential first-in-class ophthalmic recombinant human anti-VEGF-A and anti-Ang-2 bispecific antibody.
August 09, 2022
Proper screenings, treatment, management needed for this increasingly prevalent disease.
August 03, 2022
Ranibizumab-eqrn will offer greater treatment access and choice for patients, payors, and providers in the US.
July 15, 2022
Advancements enable better diagnosis, treatment of patients.
July 14, 2022
A decade after the conclusion of the NIH-funded AREDS2 study, researchers found that the AREDS2 formula also reduces the risk of lung cancer.
June 02, 2022
All data were collected in the Fight Retinal Blindness! Registry.
Ocuphire submits new drug application for eye drops for reversal of mydriasis
Getting started: methods of initial scleral lens selection
What is presbyopia?
Case report: Combination treatment proves effective for choroidal metastasis from breast cancer patient